| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total costs and expenses | 1,039,631 | 1,650,794 | 4,208,788 | 2,269,487 |
| Loss from operations | -1,018,343 | -1,632,872 | -4,208,788 | -2,260,037 |
| Interest expense | 12,959 | 7,360 | 2,400 | 8,560 |
| Amortization of debt discount | - | 0 | - | - |
| Other expense | 1,754 | 7,360 | 2,400 | 8,560 |
| Total other expense | -14,713 | - | - | - |
| Net loss | -1,033,056 | -1,640,232 | -4,211,188 | -2,268,597 |
| Basic & diluted eps | - | - | - | -0.67 |
| Basic and diluted loss per share | -0.27 | -0.43 | -1.12 | - |
| Weighted average basic and diluted shares outstanding | 3,817,172 | 3,810,065 | 3,750,079 | - |
Zivo Bioscience, Inc. (ZIVO)
Zivo Bioscience, Inc. (ZIVO)